Global In Vitro Fertilization Market

  • Product Code:
    RP-ID-10078137
  • Published Date:
    Mar 2019
  • Region:
    Global
  • Pages:
    83
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Infoholic Research
Global In Vitro Fertilization Market – Drivers, Restraints Opportunities, Trends, and Forecast up to 2024
Overview:
In Vitro Fertilization (IVF) is a process of fertilization that takes place outside the body, i.e., in vitro. IVF involves the production of eggs, i.e., superovulation, in women by medication and injecting hormones. The matured eggs are removed from ovary using oocyte aspiration systems, fertilized with the sperm of the donor, grown in a laboratory till it gets developed, and finally, the resulting embryo is implanted into the uterus. In recent years, PGD techniques are being used to screen the embryo for possible risk of passing on genetic disorders to offspring because one or both the partners may be carriers for a genetic disease. IVF also helps in maximizing the chance of conceiving in patients with a low ovarian reserve.
The in vitro fertilization market is driven by increasing awareness among the public about fertility and accessible treatment options, delayed pregnancies, reducing fertility rates, and initiation from the government to promote IVF treatment. However, high treatment cost, ethical concerns related to IVF, and low success rate of the procedure may slow down the growth of the in vitro fertilization market.
Market Analysis: The “global in vitro fertilization market” is estimated to witness a CAGR of 11.2% during the forecast period 2018–2024. The global market is analyzed based on four segments – products, cycle types, end-users, and regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). Europe is the major shareholder in the global in vitro fertilization market, followed by North America. Increasing demand for assisted reproductive technology procedures and smooth implementation of advanced technology make Europe a dominant shareholder in the market. Whereas, Asia Pacific is the fastest growing market due to increasing fertility tourism, upsurge in awareness, and acceptance of the technology.
Product Analysis: The in vitro fertilization market, by products, is segmented into reagents and instruments. Reagents include embryo culture media, cryopreservation media, sperm processing media, and ovum processing media. Instruments comprise imaging system, sperm separation system, ovum aspiration pump, micromanipulator system, incubators, cryosystems, and others. The instruments segment occupied a significant market share in 2017 and is expected to grow at a high CAGR during the forecast period.
Cycle Type Analysis: The in vitro fertilization market, by cycle type, is segmented into fresh IVF cycles (non-donor), thawed IVF cycles (non-donor), and donor IVF cycles. Fresh IVF cycles segment occupied a significant market share in 2017 and is expected to grow at a high CAGR during the forecast period due to the increased success rate in the first attempt.
End-users Analysis: The in vitro fertilization market, by end-users, is segmented into hospitals and research laboratories, fertility and surgical centers, and cryobanks. Fertility and surgical centers segment occupied a significant market share in 2017 and is expected to remain the same for the next five years due to the availability of technologically advanced IVF treatment and a broad range of fertility treatment with reimbursement facilities.
Key Players:
Thermo Fisher Scientific, Inc., Vitrolife, Cook Medical Inc., Cooper Companies (CopperSurgical Inc.), Irvine Scientific, Genea Limited, OvaScience Inc., Hunter Scientific, EMD Sereno, Inc., ESCO Micro Pte Ltd., and niche players.
Competitive Analysis:
There is an increase in acquisition, collaboration between IVF-related companies, and launching of new IVF products due to the favorable environment for IVF across the globe. For instance, in August 2018, Ferring Pharmaceuticals and Celmatix announced a collaboration, and the primary goal is to uncover new insights into ovarian biology and to accelerate the development of personalized interventions in women health and reproductive medicine. In August 2018, Thomson Medical announced to extend IVF services to China, in collaboration with assisted reproduction specialist IVI-RMA.
Benefits: The report provides complete details about the products offered by in vitro fertilization companies in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
Key Stakeholders:

Table of Contents
1 INDUSTRY OUTLOOK 8
1.1 Industry overview 8
2 Report Outline 9
2.1 Report Scope 9
2.2 Report Summary 9
2.3 Research Methodology 10
2.4 Report Assumptions 11
3 Market Snapshot 12
3.1 Market Definition – Infoholic Research 12
3.2 Advantages of in vitro fertilization 12
3.3 Disadvantage of in vitro fertilization 12
3.4 Need of in vitro fertilization 12
3.5 Process of in vitro fertilization 13
3.6 Segmented Addressable Market (SAM) 13
3.7 Trends of the in vitro fertilization market 14
3.8 Related Markets 15
3.8.1 Female Condom market 15
3.8.2 Erectile dysfunction market 15
4 Market Outlook 16
4.1 History of In Vitro Fertilization 16
4.2 Market segmentation 16
4.3 PEST Analysis 17
4.4 Porter 5(Five) Forces 18
5 Market Characteristics 20
5.1 DRO – Global In Vitro Fertilization Market Dynamics 20
5.1.1 Drivers 20
5.1.1.1 Reducing fertility rates 20
5.1.1.2 Deferred pregnancies among women 21
5.1.2 Opportunities 21
5.1.2.1 Initiation from the government to promote IVF treatment 21
5.1.2.2 Increased fertility tourism 21
5.1.3 Restraints 22
5.1.3.1 High cost of IVF treatment 22
5.1.3.2 Low success rate of IVF treatment 22
5.2 DRO – Impact Analysis 22
5.3 Key Stakeholders 23
6 Products: Market Size and Analysis 25
6.1 Overview 25
6.2 By reagents 26
6.2.1 Cryopreservation media 27
6.2.2 Sperm processing media 28
6.2.3 Embryo culture media 28
6.2.4 Ovum processing media 29
6.3 By Instruments 29
6.3.1 Imaging system 30
6.3.2 Ovum aspiration pumps 31
6.3.3 Sperm separation systems 31
6.3.4 Micromanipulator systems 31
6.3.5 Incubators 32
6.3.6 Cryosystems 32
6.3.7 Others 32
7 By Cycle type: Market Size and Analysis 33
7.1 Overview 33
7.2 Fresh IVF cycle (Non-Donor) 34
7.3 Thawed IVF cycle (Non-donor) 35
7.4 Donor egg IVF cycles 36
8 By End-Users: Market Size and Analysis 38
8.1 Overview 38
8.2 Hospitals and research laboratories 39
8.3 Fertility and surgical centers 39
8.4 Cryobanks 39
9 Regions: Market Size and Analysis 40
9.1 Overview 40
9.2 North America 41
9.3 Europe 43
9.4 Asia Pacific 44
9.5 Rest of the World 45
10 Competitive Landscape 47
10.1 Overview 47
11 Vendor Profiles 50
11.1 Thermo Fisher Scientific, Inc. 50
11.1.1 Overview 50
11.1.2 Business Units 54
11.1.3 Geographic Presence 55
11.1.4 Business focus 56
11.1.5 SWOT analysis 57
11.1.6 Business Strategy 57
11.2 Vitrolife 58
11.2.1 Overview 58
11.2.2 Geographic Presence 61
11.2.3 Business Focus 62
11.2.4 SWOT Analysis 63
11.2.5 Business Strategies 63
11.3 Cook Medical Inc. 64
11.3.1 Overview 64
11.3.2 Business Focus 66
11.3.3 SWOT Analysis 66
11.3.4 Business Strategies 66
11.4 Cooper Companies (CooperSurgical Inc.) 67
11.4.1 Overview 67
11.4.2 Business Unit 69
11.4.3 Geographic Presence 70
11.4.4 Business Focus 70
11.4.5 SWOT Analysis 71
11.4.6 Business Strategy 71
11.5 Irvine Scientific 72
11.5.1 Overview 72
11.5.2 Business Focus 74
11.5.3 SWOT Analysis 74
11.5.4 Business Strategy 75
12 Companies to Watch For 76
12.1 Genea Limited 76
12.1.1 Overview 76
12.2 EMD Sereno, Inc. 77
12.2.1 Overview 77
12.3 ESCO Micro Pte Ltd 78
12.3.1 Overview 78
12.3.2 ESCO Micro Pte Ltd: Recent Developments 79
12.4 Hunter Scientific 79
12.4.1 Overview 79
12.5 OvaScience Inc 80
12.5.1 Overview 80
12.5.2 OvaScience Inc: Recent Developments 80
12.6 Oxford Gene Technology 81
12.6.1 Overview 81
12.6.2 Oxford Gene Technology: Recent Developments 81
13 Annexure 82
13.1 Abbreviations 82

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Thermo Fisher Scientific, Inc., Vitrolife, Cook Medical Inc., Cooper Companies (CopperSurgical Inc.), Irvine Scientific, Genea Limited, OvaScience Inc., Hunter Scientific, EMD Sereno, Inc., ESCO Micro Pte Ltd., and niche players
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports